-
IntroducedJan 06, 2021
-
Passed Assembly
-
Passed Senate
-
Signed into Law
Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs
Last Action See all actions
Assembly • May 19, 2022: PRINT NUMBER 663B
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on A 663
Tweets
Whip Lists
Sponsors
- DICKENS
- WILLIAMS
- COOK
- O'DONNELL
- GRIFFIN
Votes
Actions
- May 19, 2022 | Assembly
- AMEND AND RECOMMIT TO HEALTH
- PRINT NUMBER 663B
- May 06, 2022 | Assembly
- AMEND (T) AND RECOMMIT TO HEALTH
- PRINT NUMBER 663A
- Jan 05, 2022 | Assembly
- REFERRED TO HEALTH
- Jan 06, 2021 | Assembly
- REFERRED TO HEALTH
Documents